HeLa In Vitro ABTS Radical Cation Decolorization Assay (Oxidative Stress)

CAT#: ITS-1022-YF5223
Target Cell Organism: Human
Target Cell Name: HeLa
Assay Type: Oxidative Stress Assays
Assay Overview
This assay is to provide HeLa-based In Vitro ABTS Radical Cation Decolorization Assay (Oxidative Stress) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
HeLa
Target Cell Organism
Human
Target Cell Background
In 1952, HeLa cells became the first human cell line that could grow and divide endlessly in a laboratory, leading scientists to label these cells "immortal". The immortality of HeLa cells contributed to their adoption across the world as the human cell line of choice for biomedical research.
Related Diseases
Cervical Cancer
Research Area
Oncology
Assay Name
In Vitro ABTS Radical Cation Decolorization Assay (Oxidative Stress)
Short Description
HeLa-cell based In Vitro ABTS Radical Cation Decolorization Assay (Oxidative Stress)
Assay Description
It's a commonly used simple antioxidant assay. The ability of antioxidants to reduce ABTS free radical (ABTS.) to ABTS is measured in the ABTS assay.
Assay Type
Oxidative Stress Assays
Assay Type Details
Disturbance between the production of reactive oxygen species (ROS), free radicals and antioxidant mechanisms is defined as the oxidative stress, or more precisely, it is an imbalance between the oxidant and antioxidant state in cells. This imbalance can cause harmful effects to cells and biomolecules, which ultimately causes adverse effects in the whole organism. Oxidative imbalance can target important proteinsand lipids in cells, which can increase the risk of developing a cancer. On the other hand, increased ROS production in cancer cells by certain cancer drugs can also arrest cancer cell cycle and cause senescence and apoptosis through oxidative stress.
Assay Subtype
Antioxidant Assay
For Research Use Only | Not For Clinical Use
Online Inquiry